Search

everythinglearnresearchcommunity

for

Search:↓

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

IL-18 signaling helps mature Tregs move into the thymus.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

B cells can both help and hinder the body's defense against melanoma.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Enhancing immune response can improve cancer treatment effectiveness.

CD200- cells in hair follicles have a higher ability to regenerate hair.

CD34 is crucial for skin tumor development in mice.

CD44 variant changes start alopecia areata, but don't maintain it.

Targeting regulatory T cells may help treat age-related diseases.

CD98hc's role in skin health decreases with age.

Soluble CD83 speeds up wound healing and reduces scarring.

Special cells can help regrow hair in alopecia areata.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.